GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GlaxoSmithKline PLC's cash flow for dividends for the three months ended in Dec. 2013 was $-1,041 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2013 was $-5,763 Mil.
Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.
GlaxoSmithKline PLC's quarterly payment of dividends declined from Jun. 2013 ($-1,921 Mil) to Sep. 2013 ($-1,469 Mil) and declined from Sep. 2013 ($-1,469 Mil) to Dec. 2013 ($-1,041 Mil).
GlaxoSmithKline PLC's annual payment of dividends increased from Dec. 2011 ($-5,652 Mil) to Dec. 2012 ($-6,093 Mil) but then declined from Dec. 2012 ($-6,093 Mil) to Dec. 2013 ($-6,063 Mil).
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
GlaxoSmithKline PLC Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2013 was -1332.31240429 (Mar. 2013 ) + -1921.09256449 (Jun. 2013 ) + -1468.59903382 (Sep. 2013 ) + -1041.18616145 (Dec. 2013 ) = $-5,763 Mil.
GlaxoSmithKline PLC Annual Data
GlaxoSmithKline PLC Quarterly Data